IL4I1 in M2-like macrophage promotes glioma progression and is a promising target for immunotherapy
BackgroundGlioma is the prevailing malignant intracranial tumor, characterized by an abundance of macrophages. Specifically, the infiltrating macrophages often display the M2 subtype and are known as tumor-associated macrophages (TAMs). They have a critical role in promoting the oncogenic properties...
Main Authors: | Feng Ye, Lichong Wang, Yuanyou Li, Chengyuan Dong, Liangxue Zhou, Jianguo Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1338244/full |
Similar Items
-
Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor—Glioma Therapy?
by: Ni Tong, et al.
Published: (2021-07-01) -
Glioma-associated microglia/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy
by: Chao Lin, et al.
Published: (2023-03-01) -
Macrophages in Osteosarcoma Immune Microenvironment: Implications for Immunotherapy
by: Zhong-Wei Luo, et al.
Published: (2020-12-01) -
Mechanistic studies of tumor-associated macrophage immunotherapy
by: Jiandong Cao, et al.
Published: (2024-09-01) -
Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities
by: Guoqing Wang, et al.
Published: (2022-07-01)